The Annexure

News to 9 October 2026 ·

Desk›Healthcare› Take Ltd

Take Ltd

BSE 532890 · NSE TAKE · ISIN INE142I01023 · Group B · Active

Healthcare › Healthcare › Healthcare Services › Healthcare Research, Analytics & Technology

₹17.13

-4.99%

BSE close, 28 August 2026

Market cap

₹253.41 cr

14.8 cr shares · Micro cap

Free float

₹253.03 cr

as published

P/E · P/B

43.3× · 0.85×

EPS ₹0.40 · BV ₹20.15

FY25-26 rev / PAT

— / 2.72

₹ cr, as filed

Filings, window

14

3 selected · 21%

Regime

Reg 30

Sch. III Part A

Price 52-week, BSE

52-WK LOW ₹9.85 52-WK HIGH ₹49.90 ₹17.13 18% of range
Against 52-week high-65.7%
Against 52-week low+73.9%
Day change-4.99%
Size bandMicro cap
Index membershipNone

Valuation as published by BSE

Earnings per share₹0.40
Price / earnings43.30×
Price / book0.85×
Book value — derived, price ÷ P/B₹20.15
Return on equity1.96%
Operating margin—
Net margin—

Consistency check

P/B ÷ P/E, which must equal ROE
1.96%
ROE as published
1.96%

Results ₹ crore, as filed

RevenueNet profit one scale across all three periods, ₹ crore

PeriodRevenue ₹cr Net profit ₹cr EPS ₹OPM NPM
Jun-26 · Q 11.97 0.97 0.07 8.10% 8.09%
Mar-26 · Q — 4.39 0.30 — —
FY25-26 — 2.72 0.18 — —

Quarter on quarter

Net profit, quarter on quarter
-77.9%

Disclosure profile 14 filings in the window

0 median 17.0 p75 · 25 sector max 52 14 39th percentile of 300 Healthcare filers
Shaded is the middle half of the sector, 12 to 25 filings. Measured against the 300 Healthcare companies that filed at all in this window — companies with no filings are excluded, so this is a percentile against filers rather than against the sector.
TagFilings
Selected
Board Outcome1
Press Release1
Results1
Selected sub-total3
Procedural
AGM / EGM3
Newspaper Publication2
Outcome2
Annual Report1
Board Meeting1
Postal Ballot1
Trading Window1
Procedural sub-total11
Total14

Disclosure regime

LODR Reg 30

Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.

Sources Price, day change, 52-week range — bse.quote, bse.quoteWeeklyHL, 28 August 2026 close. Market cap and free float — bse.getScripTradingStats. P/E, P/B, EPS, ROE, margins — bse.equityMetaInfo. Quarterly and annual results — bse.resultsSnapshot, standalone, as filed. Four-tier classification — data/reference/companies.csv. Filing counts and tags — the build aggregate for this window. Notes Book value is derived as price ÷ P/B; BSE does not publish it directly. Share count is derived as market cap ÷ price. Figures move between captures and between vendors, and the two are not an error in either: companies.csv carries the market cap from an earlier sweep than the snapshot above. EPS appears twice with different meanings — the figure beside P/E is the trailing one from equityMetaInfo, while the EPS in the results table is the per-period figure as filed.

Filing rhythm · 93 trading days

14 filings · 3 selected · busiest 2026-08-11

Filing rhythm · the twelve most recent

2026-08-112026-10-01

SelectedProcedural

Filings

14 in the window · 9 earlier on record

  1. 1 October 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    Submission of Voting Results along with Scrutinizer's Report for the 25th Annual General Meeting.

    AGM/EGM / AGM View filing →

  2. 29 September 2026 ·

    AGM / EGM

    Shareholder Meeting / Postal Ballot-Outcome of AGM

    Submission of Proceedings of the 25th Annual General Meeting of the Company.

    AGM/EGM / AGM View filing →

  3. 25 September 2026 ·

    Trading Window

    Closure of Trading Window

    Closure of Trading Window for the quarter and half year ending September 30, 2026.

    Insider Trading / SAST / Closure of Trading Window View filing →

  4. 9 September 2026 ·

    Newspaper Publication

    Newspaper Publication

    Submission of Newspaper Publication regarding dispatch of Notice of Annual General Meeting.

    Company Update / Newspaper Publication View filing →

  5. 7 September 2026 ·

    Annual Report

    Reg. 34 (1) Annual Report.

    Submission of Annual Report for the Financial Year 2025-26.

    Others / Reg. 34 (1) Annual Report View filing →

  6. 7 September 2026 ·

    AGM / EGM

    Notice Of The 25Th Annual General Meeting For FY 2025-26 On Tuesday, September 29, 2026 At 12:00 P.M.

    AGM of TAKE Limited to be held on Tuesday, September 29, 2026 through VC/OAVM.

    AGM/EGM / AGM View filing →

  7. 3 September 2026 ·

    Outcome

    Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday, September 3, 2026

    Outcome of the Board Meeting held on September 3, 2026, regarding declaration of 25th Annual General Meeting and Other Matters.

    Others / Outcome without intimation View filing →

  8. 1 September 2026 ·

    Outcome

    Board Meeting Outcome for Outcome Of Board Meeting Held On Tuesday, September 1, 2026

    The Board of Directors of the Company at its meeting held today, i.e. Tuesday, September 1, 2026, have inter alia considered and approved the Appointment of M/s. Tejas Nadkarni & Associates, ....

    Others / Outcome without intimation View filing →

  9. 17 August 2026 ·

    Postal Ballot

    Shareholder Meeting / Postal Ballot-Scrutinizer"s Report

    Submission of Voting Results of Postal Ballot along with Scrutinizer's Report.

    AGM/EGM / Postal Ballot View filing →

  10. 13 August 2026 ·

    Newspaper Publication

    Newspaper Publication

    Newspaper Advertisement of the Unaudited Financial Results for the quarter ended June 30, 2026.

    Company Update / Newspaper Publication View filing →

  11. 11 August 2026 ·

    Press Release

    Press Release / Media Release

    Press Release on Financial Results of the Company for the quarter ended June 30, 2026.

    Company Update / Press Release / Media Release View filing →

  12. 11 August 2026 ·

    Board Outcome

    Board Meeting Outcome for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2026

    Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2026.

    Board Meeting / Outcome of Board Meeting View filing →

  13. 11 August 2026 ·

    Results

    Unaudited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2026.

    Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2026.

    Result / Financial Results View filing →

  14. 4 August 2026 ·

    Board Meeting

    Board Meeting Intimation for Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2026.

    Take Solutions Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2026 ,inter alia, to consider and approve Unaudited Standalone and Consolidated ....

    Board Meeting / Board Meeting View filing →

RSS feed for Take Ltd · the 50 most recent filings